Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease - Wikidata - awgldk - TriplyDB

Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease

Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease

http://www.wikidata.org/entity/Q39902875

about

Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity Interleukin-22 ameliorates acute severe pancreatitis-associated lung injury in mice Inflammatory bowel disease related innate immunity and adaptive immunity Novel perspectives on therapeutic modulation of the gut microbiota Cytokine-Induced Modulation of Colorectal Cancer Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Th17 plasticity and its changes associated with inflammatory bowel disease Breast Milk and Solid Food Shaping Intestinal Immunity Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family Treg cells: a potential regulator for IL-22 expression?The mucosal immune system in the oral cavity-an orchestra of T cell diversity Review: The interleukin-23/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond Transcriptional control of innate lymphoid cells Association among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel disease Contextual functions of antigen-presenting cells in the gastrointestinal tract Inflammasomes and intestinal homeostasis: regulating and connecting infection, inflammation and the microbiota IL-22 Protects against Tissue Damage during Cutaneous Leishmaniasis IL-22 Restrains Tapeworm-Mediated Protection against Experimental Colitis via Regulation of IL-25 Expression Cytokines, IBD, and colitis-associated cancer Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice Boosting vaccine efficacy the natural (killer) way Helminthic therapy: improving mucosal barrier function Involvement of the IL-22/REG Ialpha axis in ulcerative colitis Protective and pro-inflammatory roles of intestinal bacteria IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine The Role of Interleukin-22 and Its Receptor in the Development and Pathogenesis of Experimental Autoimmune Uveitis Neuroprotection effect of interleukin (IL)-17 secreted by reactive astrocytes is emerged from a high-level IL-17-containing environment during acute neuroinflammation Dexamethasone suppresses interleukin-22 associated with bacterial infection in vitro and in vivo Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gamma HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria Leptin and mucosal immunity.Natural killer cells regulate murine cytomegalovirus-induced sialadenitis and salivary gland disease.IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic.Differentiation, distribution and gammadelta T cell-driven regulation of IL-22-producing T cells in tuberculosis Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production.A mouse model of HIES reveals pro- and anti-inflammatory functions of STAT3.Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17.CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.Interaction between the gut microbiome and mucosal immune system.

P2860

Q24597173-25A2B338-3E16-4ACB-B832-E5442691171E Q24642507-BD45FBF5-B5BE-47C9-8B1B-C48BBFDD8311 Q24658609-7DC734F7-64D5-4ED7-97EB-02924F504967 Q26741407-32E9CC48-5446-45C4-B162-8150E418D36A Q26745706-85588F1E-DEAA-485D-ABA6-CFFA80E10074 Q26752374-3DE8BD96-9D41-4231-93EE-5146D043506C Q26752528-9D9DF1EA-B3C2-469C-A473-EC5CAFC4C940 Q26775934-1BDE5C53-2FCC-45EF-9A73-D7E92F1DCC17 Q26782801-9D5D1A19-1C1B-483B-87E0-3C291CFF5790 Q26801150-64FB1CE1-16CE-4E1C-849C-AE0AA1DF44C6 Q26824855-3F3741D9-290A-41EA-AF65-6449610E43A4 Q26851091-0F4ED2D8-C424-4B19-8909-13FF5E876BDA Q26991709-51EA6527-31D2-4D8F-9ACA-A96006C0FFCA Q27005868-6A75B5D9-068C-49E6-8013-C420DC270DEB Q27006589-DB71373F-B9D9-4D57-85A0-4ABEBE6C3E2B Q27009419-F6FA818B-C19F-4838-860F-E2814248FFAA Q27025039-E4D188BC-8326-41FA-85C6-EDF8FA51E951 Q27301071-6840ED5D-3156-4439-8FA1-E2831C39A300 Q27315163-3BF04F2B-E3DA-42D6-972B-F93603E3C42D Q28080901-236DE77B-019D-4414-8C9A-3521C1BD6D89 Q28081074-D2319F31-CA88-4C7D-8687-8FE7BDDB8A64 Q28084474-DE4E45BB-2A95-4712-B90D-E7CA5B03F986 Q28263272-E4CCB4FF-2509-4106-9306-A3537C8A29C5 Q28270049-F1D856D2-4287-49E7-840F-73055677D185 Q28273923-218C8CAC-F9BF-4DCB-8E6F-8FD11794990B Q28506198-44B5E04E-F210-4620-A84C-F59BA7F2E5A1 Q28551977-9AEF5F4F-D3B5-497C-91CE-4A51723CA39F Q28565232-EF9125CD-D4A6-4165-8AE9-E3EB87334F31 Q28573335-4431B332-FD5E-4539-99EC-6AA9EF2CBC1B Q28587904-20E184CB-3AF2-455C-A2D9-CDA9A8E5DD85 Q28590892-06BB3786-D472-4AAC-B4CE-E7BF9BA462D5 Q30422264-061E16E0-DF33-4A6B-B256-2DA9487DAA49 Q30425772-A9296A43-E537-49AA-9A63-6A2FE1C7591D Q30539616-1F6CD2A7-9A00-4178-95A9-968CBF3F687E Q33535840-E4F1A929-F3DA-4E63-8B42-48FAC00B0207 Q33564666-60B44503-4E30-4027-9C3C-8B16E4545BB3 Q33585268-70087406-B1E7-4D63-BF58-9AEDA6D5AF53 Q33590409-78F2538D-7442-4F58-A136-EBEFB3F75854 Q33597507-8DB16810-ACAD-4900-9B1A-5580F09FC81A Q33612504-F2DA0E53-48A9-49CD-8C9E-2BBF3E541C4D

P2860

Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease

http://www.wikidata.org/entity/Q39902875

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease

@en

Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease.

@nl

type

label

Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease

@en

Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease.

@nl

prefLabel

Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease

@en

Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease.

@nl

P1433

Q39902875-753F37CE-3A3E-49E7-BC07-ECDC2085BB5B

P1476

Q39902875-A25A2A6A-4B3F-4368-AFCF-84E79D33849F

P2093

Q39902875-17BFD209-598D-42A7-BF21-6DD6A8BECEEC

Q39902875-3B76464D-D0B1-490F-85BF-D13279365B69

Q39902875-41F66018-BF71-42D6-B954-10EA7398A949

Q39902875-6713AD4B-1686-41A0-867D-D3F2A2FED16F

P2860

Q39902875-04CED11D-D666-4952-AAD8-C0EBE678CCCD

Q39902875-088FD955-3126-4F40-A19B-C092CA9009DB

Q39902875-0F9999F0-0695-460F-BDEC-501A57E48D68

Q39902875-1CCF5DA1-6D23-44A7-AE08-AE0942C35CB7

Q39902875-27D8828A-198F-458F-85AE-2347EFA02CA9

Q39902875-2ACE0320-4877-4325-A1E3-220EE48D1DF5

Q39902875-359128C6-B736-44D6-9994-3B6DA7339943

Q39902875-3C39836B-B9B9-42D0-8C5F-82B7BDACB195

Q39902875-475F7FB3-4343-494C-8407-EA34C4566EF7

Q39902875-4FC0B562-1988-4833-909D-D333427405E5

P304

Q39902875-7413552A-CB89-45FD-81F1-BA8D582593BA

P31

Q39902875-8E60C94B-BF57-44EA-AC3C-3C0A4FFF7E6B

P356

Q39902875-A763A5B1-7C28-4696-A746-0894A2DABB89

P407

Q39902875-E2DF3C55-3ECF-43CB-9688-61FE91FA775F

P433

Q39902875-B0F56850-9135-49AA-A526-664F70C91E58

P478

Q39902875-BF988B92-6D95-4E10-B07C-82698A9192F6

P50

Q39902875-8B9AA381-A256-41C1-AEA5-9D8BCDEF69C0

Q39902875-E5FB5E3A-739D-4E31-A94C-EF57EE01F2FB

P577

Q39902875-0F112347-AB34-42EF-9B36-387E898C90A4

P5875

Q39902875-3B68C4FB-86BC-4D80-A02E-2C3F82279975

P698

Q39902875-2D2641CE-697D-4998-8B9B-0CA6225B6E5C

P921

Q39902875-42CD12B6-88D0-4E78-9ABA-977D5BD971BD

Q39902875-FE450AE9-06FC-4D42-8412-AC2735A4535C

Q39902875-d94bc4bd-dc15-4613-a224-9f2682834182

P932

Q39902875-13BE3B38-0BC8-4A99-9EB2-E20E344B7986

P356

J.IMMUNI.2008.11.003

P1433

P1476

Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease

@en

P2093

David M Valenzuela

http://www.w3.org/2001/XMLSchema#string

George D Yancopoulos

http://www.w3.org/2001/XMLSchema#string

Richard A Flavell

http://www.w3.org/2001/XMLSchema#string

Sean Stevens

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammatory Bowel Disease

Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor

Interleukin-10 and the interleukin-10 receptor

Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

Interleukin-23 drives innate and T cell-mediated intestinal inflammation

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

IL-22 increases the innate immunity of tissues

P304

947-957

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IMMUNI.2008.11.003

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Andrew J Murphy

Lauren A Zenewicz

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23682238

http://www.w3.org/2001/XMLSchema#string

P698

19100701

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

3269819

http://www.w3.org/2001/XMLSchema#string